Biolife solutions stock.

BioLife Solutions Reports Third Quarter 2023 Financial Results. BioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading supplier of biopreservation media and other cell processing tools and biostorage services for the cell and gene... Nov 02, 2023.

Biolife solutions stock. Things To Know About Biolife solutions stock.

This report will help you with various insights regarding the recent year performance of BioLife Solutions Inc (BLFS) stock.The corporate mailing address for Ms. Aebersold and other BioLife Solutions executives is 3303 MONTE VILLA PARKWAY SUITE 310, BOTHELL WA, 98021. BioLife Solutions can also be reached via phone at (425) 402-1400 and via email at [email protected]. Learn More on Sarah Aebersold's contact information.BioLife Solutions, Inc. (NASDAQ:BLFS – Get Rating) major shareholder Casdin Partners Master Fund, L acquired 15,000 shares of BioLife Solutions stock in a transaction on Tuesday, May 16th.The shares were bought at an average price of $20.19 per share, for a total transaction of $302,850.00. Following the purchase, the insider now …Oct 16, 2023 · BioLife Solutions to Report Fourth Quarter and Full Year 2022 Financial Results and Provide Business Update on March 16, 2023. BOTHELL, Wash. , March 9, 2023 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapies ("CGT") and...

Rhumbline Advisers decreased its holdings in BioLife Solutions, Inc. (NASDAQ:BLFS – Free Report) by 8.1% in the second quarter, Holdings Channel.com …Shares of BioLife Solutions (BLFS 7.11%) were down more than 37% for the week, as of 3:15 p.m. ET on Friday, ... The healthcare company's stock closed last week at $19.22, then dropped to a 52 ...

Stock analysis for BioLife Solutions Inc (BLFS:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

Broadridge Corporate Issuer Solutions, Inc. P.O. Box 1342 Brentwood, New York 11717 USA (877) 830 - 4936 [email protected] Solutions is introducing initial 2023 revenue guidance, which is based on expectations for its existing business. Expected growth rates are all based on preliminary unaudited revenue. Total revenue for 2023 is expected to range from $188 million to $202 million, reflecting year-over-year growth of 16% to 25%. Excluding COVID related ...BioLife Solutions, Inc. (BLFS) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? By taking a look at the ...The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 10.89% during the next 3 months and, with a 90% probability hold a price between $0.00000328 and $0.0002 at the end of this 3-month period.

BioLife Solutions, Inc. (NASDAQ:BLFS) Q3 2023 Earnings Call Transcript November 9, 2023 BioLife Solutions, Inc. beats earnings expectations. Reported EPS is $-0.3, expectations were $-0.38. Operator: Good afternoon, ladies and gentlemen, and thank you for standing by. Welcome to the BioLife Solutions Third Quarter 2023 Shareholder and Analyst ...

May 3, 2021 · BioLife issued 6,646,870 shares of common stock in exchange for 100% of the outstanding shares of Stirling. BioLife management has provided guidance for Stirling's 2021 post-closing revenue contribution to be $35 million to $37 million , with total 2021 revenue of $101 million to $110 million .

Biolife Solutions will release earnings for Q1 on May 10. Wall Street predict expect Biolife Solutions will release losses per share of $0.213. Go here to watch Biolife Solutions stock price in ...Nowadays finding high-quality stock photos for personal or commercial use is very simple. You just need to search the photo using a few descriptive words and let Google do the rest of the work.BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies.Mar 22, 2021 · Athens, Ohio, March 22, 2021 — Stirling Ultracold, a privately-held innovative developer and manufacturer of ultra-low temperature (ULT) freezers, today announced it has signed a definitive agreement to merge into BioLife Solutions (NASDAQ: BLFS) to combine expertise and expand individual product offerings for biopharma research and life ... Complete BioLife Solutions Inc. stock information by Barron's. View real-time BLFS stock price and news, along with industry-best analysis.Stock Price. $10.2. 2023-11-01. Market Capitalization. $457.1 M. 2023-11-01. Revenue. $161.8 M. FY, 2022. BioLife Solutions Summary. Company Summary. Overview. Bothell, WA-based BioLife Solutions, Inc. is a developer, manufacturer and marketer of proprietary clinical grade cell and tissue hypothermic storage and cryopreservation freeze media ...

Broadridge Corporate Issuer Solutions, Inc. P.O. Box 1342 Brentwood, New York 11717 USA (877) 830 - 4936 [email protected] store valuable samples at ultra-low temperatures from -20°C to -86°C. The ULT25NEU holds 18 2-inch boxes in a portable and lightweight 25-liter (0.9 cu. ft.) size, made possible by our breakthrough ULT technology. Designed for space and energy efficiency, the ULT25NEU ultra-low temperature freezer uses less than 2.8 kWh/day at …BioLife Solutions (NASDAQ:BLFS) and Zynex (NASDAQ:ZYXI) are both small-cap medical companies, but which is the superior stock?We will contrast the two companies based on the strength of their dividends, risk, earnings, profitability, valuation, analyst recommendations, institutional ownership, media sentiment and community ranking.BioLife Solutions Stock Price, News & Analysis (NASDAQ:BLFS) $12.51 -0.24 (-1.88%) (As of 05:28 PM ET) Compare Today's Range $12.46 $13.62 50-Day Range $8.99 …/PRNewswire/ -- BioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), ... for $24.0 million, in consideration for 506,382 newly issued shares of BioLife common stock. Taking into ...

BioLife Solutions's headquarters are located at 3303 Monte Villa Pkwy Ste 310, Bothell, Washington, 98021, United States What is BioLife Solutions's phone number? BioLife Solutions's phone number is (425) 402-1400 What is BioLife Solutions's stock symbol?Chief Quality Officer Of Biolife Solutions Trades $760K In Company Stock. (Benzinga) Sep-20-21 08:00AM. BioLife Solutions Appoints Joydeep Goswami, MBA, PhD to Board of Directors. (PR Newswire) BioLife Solutions, Inc. engages in the development, manufacture and marketing of bio preservation tools for cells and tissues. Its product offerings ...

Nov 16, 2023 · Headquartered in Bothell, Washington, BioLife Solutions, Inc. (NASDAQ:BLFS) is a bioproduction tools and services provider. On November 15, 2023, BioLife Solutions, Inc. (NASDAQ:BLFS) stock closed ... BioLife Solutions is trading near 52-week lows as its growth story has floundered and profitability remains uncertain. Learn why I rate BLFS stock a hold.Hedge fund activity in BioLife Solutions, Inc. (NASDAQ:BLFS) Heading into the second quarter of 2020, a total of 9 of the hedge funds tracked by Insider Monkey were long this stock, a change of ...BOTHELL, Wash., July 7, 2020 / PRNewswire / -- BioLife Solutions, Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of a portfolio of class-defining bioproduction tools for cell and gene therapies, today announced the closing of its public offering of 5,951,250 shares of common stock at the public offering price ...BioLife Solutions Reports First Quarter 2023 Financial Results. Revenue of $37.7 million increased 4% over Q1 2022, ex-COVID growth of 16% and biopreservation media revenue growth of 28%. Q1 2023 ...May 10, 2023 · BioLife Solutions Reports First Quarter 2023 Financial Results. Revenue of $37.7 million increased 4% over Q1 2022, ex-COVID growth of 16% and biopreservation media revenue growth of 28%. Q1 2023 ... BioLife Solutions, Inc. is a life sciences company. The Company develops, manufactures, and markets bioproduction tools and services which are designed to de-risk biologic manufacturing, storage, distribution, and transportation in the cell and gene therapy (CGT) industry and broader biopharma markets.Name. Chg %. Market Cap. Evogene Ltd. -1.07%. $30.17M. BLFS | Complete BioLife Solutions Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial...BioLife Solutions is a class-defining cell and gene therapy bioproduction tools and services company. Our solutions give life science companies and clinical researchers significant improvement in shelf life and post-preservation viability and function of biological materials. BioLife Solutions is one of Washington’s best places to work ...

BOTHELL, Wash., April 6, 2021 / PRNewswire / -- BioLife Solutions, Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of a portfolio of class-defining bioproduction products and services for cell and gene therapies, today announced that it has appointed Amy DuRoss, chief executive officer of Vineti, and Rachel ...

The Stirling Ultracold SU780XLE is an energy-efficient upright ultra-low temperature (ULT) freezer. Compared to other compressor-based upright ULTs, the SU780XLE: Compressor technology is expected to fail — putting your valuable samples at risk. But because the SU780XLE ultra-low freezer uses Stirling engine technology to keep your samples safer.

BLFS BioLife Solutions stock chart. #fintwits #money #wallstreet #stockmarket #stocks. 0 points. 1 comment. 1. 0 comments. share. save. 2. Posted by 2 years ago. I want to buy a trading bot, any recommendations here? 2. 3 comments. share. save. 1. Posted by 2 years ago. Adam Khoo FX trading. Hello! I got some courses a while back and have decided to …Mar 22, 2021 · With Stirling, BioLife believes that total GAAP revenue in 2021 will exceed $100 million and the transaction is expected to be accretive on an adjusted Net Income per share basis (Non-GAAP) in ... Get the latest BioLife Solutions Inc (BLFS) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment …Nov 9, 2022 · BioLife Solutions, Inc. (BLFS) came out with a quarterly loss of $0.23 per share versus the Zacks Consensus Estimate of a loss of $0.18. This compares to break-even earnings per share a year ago ... Shares of BioLife Solutions (BLFS 7.11%) were down more than 37% for the week, as of 3:15 p.m. ET on Friday, ... The healthcare company's stock closed last week at $19.22, then dropped to a 52 ...The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 10.89% during the next 3 months and, with a 90% probability hold a price between $0.00000328 and $0.0002 at the end of this 3-month period.According to the issued ratings of 5 analysts in the last year, the consensus rating for BioLife Solutions stock is Buy based on the current 5 buy ratings for BLFS. The average twelve-month price prediction for BioLife Solutions is $24.60 with a high price target of $28.00 and a low price target of $22.00. Learn more on BLFS's analyst rating ...BioLife Solutions is a class-defining cell and gene therapy bioproduction tools and services company. Our solutions give life science companies and clinical researchers significant improvement in shelf life and post-preservation viability and function of biological materials. BioLife Solutions is one of Washington’s best places to work ...

BioLife Solutions Trading Up 2.5 %. NASDAQ BLFS traded up $0.33 on Monday, hitting $13.58. 44,504 shares of the stock were exchanged, compared to its average volume of 403,529. The company’s 50 ...The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 10.89% during the next 3 months and, with a 90% probability hold a price between $0.00000328 and $0.0002 at the end of this 3-month period.Four times named as one of the top 100 Companies to work for in Washington state (2022, 2020, 2015, and 2013), BioLife Solutions Inc. is a multi-platform provider of bioproduction tools and services to the cell and gene therapy and broader biopharma markets. Learn more.BioLife Solutions Inc (ISIN: US09062W2044, WKN: A1XCF2): ✓ Precio Acciones BioLife Solutions Inc ✓ Rendimiento de Dividendos y Fechas, ✓ News ✓ Plan de ...Instagram:https://instagram. apple cash flowinvest in fractional real estatehow much is a brick of goldfutures trading classes Management will provide an overview of the Company's financial results and a general business update. To access the webcast, log onto the Investor Relations ...BioLife Solutions stock scales 10% on acquisition of Stirling Ultracold SA News Mon, Mar. 22, 2021 4 Comments BioLife Solutions EPS misses by $0.01, beats on revenue honeywell forgebest otc broker Athens, Ohio, March 22, 2021 — Stirling Ultracold, a privately-held innovative developer and manufacturer of ultra-low temperature (ULT) freezers, today announced it has signed a definitive agreement to merge into BioLife Solutions (NASDAQ: BLFS) to combine expertise and expand individual product offerings for biopharma research and life ... onfolio BOTHELL, Wash., May 2, 2023 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapies ("CGT") and broader biopharma markets, today announced the Company's first quarter financial results will be released after market close on Wednesday, May 10, 2023.5 Wall Street analysts have issued 1 year target prices for BioLife Solutions' stock. Their BLFS share price targets range from $22.00 to $28.00. On average, they expect the company's stock price to reach $24.60 in the next year. This suggests a possible upside of 91.7% from the stock's current price. View analysts price targets for BLFS or ...